Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

44 results about "Influenza virus Antibody" patented technology

FI6 is an antibody that targets a protein found on the surface of all influenza A viruses called hemagglutinin. FI6 is the only known antibody found to bind all 16 subtypes of the influenza A virus hemagglutinin and is hoped to be useful for a universal influenza virus therapy.

Influenza virus antibodies and immunogens and uses therefor

The present invention is directed to particular monoclonal antibodies and fragments thereof that find use in the detection, prevention and treatment of influenza virus infections. In particular, these antibodies may neutralize or limit the replication of influenza virus. Also disclosed are improved methods for producing such monoclonal antibodies, including novel immunogens for use in vaccination and production of protective immune responses.
Owner:VANDERBILT UNIV

Nanobody capable of resisting H9N2 subtype avian influenza viruses, preparation method and application

The invention discloses a nanobody capable of resisting H9N2 subtype avian influenza viruses, a preparation method and an application. The amino acid sequence of the nanobody is as shown in SEQID NO:1. The nucleocapsid protein of the H9N2 subtype avian influenza viruses is expressed through a prokaryotic expression technique, then the nucleocapsid protein is used as an immunogen for immunizing Bactrian camels, a phage library is constructed, then a nanobody capable of resisting H9N2 nucleocapsid protein is obtained through screening by a phage display technique, then the nanobody and horse radish peroxidase (HRP) are subjected to fusion expression, and a fusion protein of the nanobody and the HRP is successfully prepared. When the fusion protein is applied to detection of antibodies capable of resisting H9N2 subtype avian influenza viruses (AIV) in chicken serum, the inventor finds that a detection method constructed through the fusion protein is high in sensitivity, and has the advantages that the operation is simple, secondary antibodies do not need to be used, and time consumed for detecting samples is short.
Owner:NORTHWEST A & F UNIV

A-type H1 subtype influenza virus antibody blocking ELISA kit and applications thereof

The invention discloses an A-type H1 subtype influenza virus antibody blocking ELISA kit. The kit comprises: a) an A-type H1 subtype influenza virus A-Influ / JML-F9; b) a monoclonal antibody with strong specificity of an A-type H1 subtype influenza virus-resistant hemagglutinin protein; c) an antibody blocking ELISA core kit prepared from the monoclonal antibody of the A-type H1 subtype influenza virus-resistant hemagglutinin protein; and d) a sample diluting liquid, 10 times of a washing liquid, a substrate liquid A, a substrate liquid B, a reaction stop solution, a positive control sample and a negative control sample in the kit. The invention also discloses applications of the A-type H1 subtype influenza virus antibody blocking ELISA kit in A-type H1 subtype influenza virus antibody detection. The kit has strong specificity, high sensitivity, short detection time, easy and practical operation, and no need of being operated by a professional person. The kit is good in stability and long in retention period, and solves a problem of the A-type H1 subtype influenza virus antibody detection.
Owner:HUAZHONG AGRI UNIV

Device for detecting avian influenza virus antibody and detection method

This invention disclose a kind of equipment used to detect the fowl influenza virus antibody correctly, fast, sensitively, with high specificity and economically. The equipment includes immunity sensor, enzyme labeled double antibody reaction system, electrolytic cell and data collection and process system; the immunity sensor includes the electrode system which is composed with the work electrode, the reference electrode and the assistant electrode which are printed in the insulated base plate; the electrolytic cell includes the detection base liquid, the beater and the temperature controller; the data collection and process system includes the electrochemistry workstation, the computer and the software system; the immunity sensor connects the electrochemistry workstation by lead; the work electrode of the immunity sensor is carbon electrode, which has coated the gold size induction film embed fowl influenza virus antibody. This invention also discloses a kind of method to use the equipment to detect the fowl influenza virus antibody.
Owner:ZHEJIANG GONGSHANG UNIVERSITY +1

Anti-H9 subtype avian influenza virus monoclonal antibody, hybridoma cell strain and application of monoclonal antibody

The invention discloses an anti-H9 subtype avian influenza virus monoclonal antibody which is bound with HA protein of an H9 subtype avian influenza virus and has hemagglutination inhibition activity. The invention further discloses a reagent kit for detecting the H9 subtype avian influenza virus antibody, and an application of the monoclonal antibody to preparation of an avian influenza diagnosis product. The reagent kit for detecting the H9 subtype avian influenza virus antibody has good specificity and sensitivity, is applicable to antibody detection and screening of massive different host serums, and has good application prospects in diagnosis and the antibody detection of H9 subtype avian influenza virus diseases.
Owner:SHANGHAI VETERINARY RES INST CHINESE ACAD OF AGRI SCI

Broad-spectrum monoclonal Anti-flu b antibody and uses thereof

Provided are a broad-spectrum monoclonal anti-Flu B antibody, cell strains generating the antibody, and a composition comprising the antibody; also provided are uses of the antibody for diagnosing, preventing and / or treating an infection of the Flu B and / or diseases caused by the infection.
Owner:XIAMEN UNIV

Influenza virus antibody and preparation method and application thereof

The invention relates to the biotechnology field, in particular to an influenza virus antibody. A light-chain variable region of the influenza virus antibody has an amino acid sequence shown as the SEQ ID No.1; a heavy-chain variable region of the influenza virus antibody has an amino acid sequence shown as the SEQ ID No.2. The antibody can well neutralize H3N2, H4N6 and H14N5 subtype influenza viruses, combine HA proteins of all subtype influenza viruses in a group 2, neutralize H3-subclade viruses and inhibit copying of the H3 subtype influenza viruses in a mouse body and has the important economic and social significance.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI +1

Novel epitope and mechanism of antigen-antibody interaction in an influenza virus

Antibodies (Abs) play roles in protection against influenza. Neutralizing Abs either inhibit the binding of hemagglutinin (HA) to cellular receptors or prevent the conformational change of HA induced by low pH. The former Ab binds to the regions near the sialic acid-binding pocket on the globular head formed by HA1 and generally shows narrow strain specificity. The latter Ab binds to the stem region formed mainly by HA2 and shows broad strain specificity. We isolated a broadly neutralizing Ab against H3N2 viruses. X-ray analysis of the HA / Ab complex indicated that the Ab binds to the valley formed by two neighboring HA monomers at the side of the globular head. The Ab shows neutralizing activity by preventing the conformational change of HA induced at low pH.
Owner:FUJITA HEALTH UNIVERSITY

Application of polymorphism of rs12252 in detecting influenza virus antibody

ActiveCN108330196AMicrobiological testing/measurementInfluenza B antibodyHuman DNA sequencing
The invention discloses an application of polymorphism of rs12252 in detecting an influenza virus antibody. The technical scheme protected by the invention comprises that provided is an application ofa substance, used for detecting the polymorphism or genotype of the rs12252 in a human genome, in preparation of products for detection or assisted detection of the level of an antibody, aiming at H1N1pdm09 influenza virus, in young people, an application in preparation of a product for screening young people suggested to be inoculated with a vaccine for preventing influenza caused by the H1N1pdm09 influenza virus, or an application in preparation of a product for detecting the resistibility of young people on the H1N1pdm09 influenza virus. The substance can be used for screening the young people suggested to be injected with the vaccine for preventing the influenza caused by the H1N1pdm09 influenza virus.
Owner:BEIJING YOUAN HOSPITAL CAPITAL MEDICAL UNIV

Influenza B virus IgA (immunoglobulin A) antibody immunofluorescence assay test strip and preparation method, detection method and application thereof

The invention provides an influenza B virus IgA (immunoglobulin A) antibody immunofluorescence assay test strip and a preparation method thereof. The influenza B virus IgA antibody immunofluorescenceassay test strip comprises a sample pad, a label pad, a nitrocellulose membrane, a water absorbing paper and a back plate, wherein the nitrocellulose membrane comprises a detection line for influenzaB virus NP (nucleoprotein) antigen polypeptide segments, and a human IgA antibody contrast line; the label pad is provided with an anti-human IgA antibody-fluorescent microsphere marker. The influenzaB virus IgA antibody immunofluorescence assay test strip has the advantages that the detection sensitivity is very high, a high-cost PCR (polymerase chain reaction) detection instrument is not needed, the detection result can be known by naked eyes, and the influenza B virus can be quickly screened. The invention also provides a detection method and application of the influenza B virus IgA antibody immunofluorescence assay test strip. The detection method has the advantages that the steps are simple, the operation is easy, the results are quick, and the detection method is suitable for beingwidely popularized.
Owner:GUANGZHOU RHFAY BIOTECH CO LTD

Method for detecting influenza virus antibody through agglutination reaction based on eukaryotic cell for recombinant expression on influenza virus hemagglutinin and neuraminidase

The invention relates to the technical field of biology, in particular to a method for detecting an influenza virus antibody through agglutination reaction based on an eukaryotic cell for recombinant expression on influenza virus hemagglutinin and neuraminidase. The method comprises the following steps of: taking the eukaryotic cell for the recombinant expression on the influenza virus hemagglutinin and the neuraminidase as an agglutination reaction matrix, and detecting the influenza virus hemagglutinin antibody and the neuraminidase antibody in a sample to be detected through the recombinant expression of the influenza virus hemagglutinin and the neuraminidase in the agglutination reaction way. In the invention, the influenza virus hemagglutinin and the neuraminidase are co-expressed on the surface of the eukaryotic cell, thereby effectively avoiding self-coagulation to affect the agglutination reaction due to the combination of the hemagglutinin and a cell receptor; at the same time, the invention can more widely and rapidly detect the influenza virus antibody in different serotypes.
Owner:SHANTOU UNIV MEDICAL COLLEGE

Fluorescence micro cell agglutination method for detecting influenza virus antibody

The invention relates to the biological technology field, in particular to a fluorescence micro cell agglutination method for detecting influenza virus antibody. The method in the invention comprises the following steps: hemagglutinin gene and neuraminidase gene of influenza virus are cloned and then are transfected to a eukaryotic cell; the hemagglutinin and neuraminidase are recombined and expressed on the surface of the eukaryotic cell; the recombinant expression cell is marked by fluorescence; the hemagglutinin and neuraminidase which are recombined and expressed on the surface of the cell are combined with hemagglutinin antibody and neuraminidase antibody of the influenza virus to carry out agglutination reaction; and pictures are taken by a fluorescence microscope, whether influenza virus antibody exists in a to-be-detected sample is judged according to whether the fluorescence area is increased. In the detecting method of the invention, the cell marked by fluorescence is used, the cell using amount is reduced, high-throughput detection can be carried out, and quick detection, early detection, on-spot detection and evaluation of the influenza virus antibody can be realized.
Owner:SHANTOU UNIV MEDICAL COLLEGE

Humanized influenza monoclonal antibodies and methods of use thereof

The present invention provides structural determinants important for binding to the stem domain of the HA protein of influenza virus, and methods of use thereof for production of high affinity neutralizing influenza virus antibodies based upon these determinants. The present invention further provides tools for determining the efficacy of an influenza virus vaccine. The present invention further provides a molecular signature useful for determining the efficacy of an influenza virus vaccine in a subject, or for predicting prior immunologic exposure or antigen responsiveness to vaccine or influenza virus infection.
Owner:DANA FARBER CANCER INST INC

Humanized influenza monoclonal antibodies and methods of use thereof

The present invention provides structural determinants important for binding to the stem domain of the HA protein of influenza virus, and methods of use thereof for production of high affinity neutralizing influenza virus antibodies based upon these determinants. The present invention further provides tools for determining the efficacy of an influenza virus vaccine. The present invention further provides a molecular signature useful for determining the efficacy of an influenza virus vaccine in a subject, or for predicting prior immunologic exposure or antigen responsiveness to vaccine or influenza virus infection.
Owner:DANA FARBER CANCER INST INC

Preparation method of swine H1N1 subtype influenza virus hemagglutinin recombinant protein and liquid phase chip detection kit for virus antibody

The invention first provides a preparation method of a swine H1N1 subtype influenza virus hemagglutinin (HA) recombinant protein. A pair of primers with HIS labels is designed by removing a signal peptide of the HA according to an HA sequence, and a prokaryotic expression plasmid with a 6*His-maltose-binding protein (MBP) combination label is constructed; the HA recombinant protein expressed in a soluble form is successfully obtained in an Escherichia coli expression system and can generate reaction with a mouse antibody with swine H1N1 subtype influenza virus HA, thereby showing that the HA recombinant protein has good antigenicity; a liquid phase chip detection technology is established by using the HA recombinant protein and is higher than ELISA (Enzyme-Linked Immuno Sorbent Assay) in sensitivity; the establishment of the method provides necessary technical supplement for detecting a swine influenza virus antibody, lays a technical basis for researching the liquid phase chip detection technologies of other epidemic disease antibodies, and provides a test reference for establishing multiple liquid phase chip detection technologies of multiple swine disease antibodies.
Owner:SOUTH CHINA AGRI UNIV

Immunogenetic restriction on elicitation of antibodies

InactiveUS20170174751A1Improving neutralization capacityHigh affinityMicrobiological testing/measurementImmunoglobulins against virusesInfluenza virus vaccineImmunogenetics
The present invention provides structural determinants important for binding to the stem domain of the HA protein of influenza virus, and methods of use thereof for production of high affinity neutralizing influenza virus antibodies based upon these determinants. The present invention further provides tools for determining the efficacy of an influenza virus vaccine. The present invention further provides a molecular signature useful for determining the efficacy of an influenza virus vaccine in a subject, or for predicting prior immunologic exposure or antigen responsiveness to vaccine or influenza virus infection.
Owner:DANA FARBER CANCER INST INC

Anti-h9n2 subtype avian influenza virus nanobody, preparation method and application

The invention discloses a nanobody against H9N2 subtype avian influenza virus, a preparation method and an application. The amino acid sequence of the nanobody is shown in SEQ ID NO:1. The present invention expresses the nucleocapsid protein of H9N2 subtype avian influenza virus through prokaryotic expression technology, and then uses it as an immunogen to immunize Bactrian camels, constructs a phage library, and obtains an anti-H9N2 nucleocapsid strain by screening with phage display technology Protein nanobody, and the fusion expression of the nanobody and horseradish peroxidase (HRP), successfully prepared the fusion protein of the nanobody and HRP, and applied the fusion protein to the detection of anti-H9N2 subtype poultry in chicken serum Among influenza virus (AIV) antibodies, it was found that the detection method constructed by the fusion protein has high sensitivity, and has the advantages of simple operation, no need to use secondary antibodies, and short time-consuming detection of samples.
Owner:NORTHWEST A & F UNIV

Method for detecting influenza virus antibody through agglutination reaction based on eukaryotic cell for recombinant expression on influenza virus hemagglutinin and neuraminidase

The invention relates to the technical field of biology, in particular to a method for detecting an influenza virus antibody through agglutination reaction based on an eukaryotic cell for recombinant expression on influenza virus hemagglutinin and neuraminidase. The method comprises the following steps of: taking the eukaryotic cell for the recombinant expression on the influenza virus hemagglutinin and the neuraminidase as an agglutination reaction matrix, and detecting the influenza virus hemagglutinin antibody and the neuraminidase antibody in a sample to be detected through the recombinant expression of the influenza virus hemagglutinin and the neuraminidase in the agglutination reaction way. In the invention, the influenza virus hemagglutinin and the neuraminidase are co-expressed on the surface of the eukaryotic cell, thereby effectively avoiding self-coagulation to affect the agglutination reaction due to the combination of the hemagglutinin and a cell receptor; at the same time, the invention can more widely and rapidly detect the influenza virus antibody in different serotypes.
Owner:SHANTOU UNIV MEDICAL COLLEGE

Stable liquid pharmaceutical formulation of Anti-influenza virus antibody

A stable liquid pharmaceutical preparation of an anti-influenza virus antibody and, more specifically, a stable liquid pharmaceutical preparation that comprises: (A) an anti-influenza virus antibody or a mixture of two or more different types of anti-influenza virus antibodies; (B) a surfactant; (C) a sugar or a sugar derivative; and (D) an amino acid. The stable liquid pharmaceutical preparation for an anti-influenza virus antibody disclosed herein has excellent storage stability at low temperature (5° C.), room temperature (25° C.), and high temperature (40° C.) and excellent long-term (12 months) storage stability, and may be administered intravenously, intramuscularly, transdermally, subcutaneously, intraperitoneally, topically, or in combinations thereof.
Owner:CELLTRION INC

Anti-H9N2 subtype avian influenza virus polypeptide and application thereof

The invention belongs to the technical field of animal medical molecular immunology, and particularly relates to an anti-H9N2 subtype avian influenza virus polypeptide and an application thereof. The polypeptide for resisting the H9N2 subtype avian influenza virus has an amino acid sequence of RRKKWLVFFVIFYFFR, is applied to preparation of drugs for treating the avian influenza virus, and can also be combined with one or more of antiviral traditional Chinese medicines, interferon, influenza virus antibodies, transfer factors and the like to prepare products for resisting the H9N2 subtype avian influenza virus.
Owner:山东省健牧生物药业有限公司

Device for detecting avian influenza virus antigen and detection method

This invention discloses a kind of equipment used to detect the fowl influenza virus antibody correctly, fast, sensitively, with high specificity and economically. The equipment includes immunity sensor, electrolytic cell and data collection and process system; the immunity sensor includes the electrode system which is composed with the work electrode, the reference electrode and the assistant electrode which are printed in the insulated base plate; the electrolytic cell includes the detection base liquid, the beater and the temperature controller; the data collection and process system includes the electrochemistry workstation, the computer and the software system; the immunity sensor connects the electrochemistry workstation by lead; the work electrode of the immunity sensor is carbon electrode, which has coated the gold size induction film embed fowl influenza virus antibody. This invention also discloses a kind of method to use the equipment to detect the fowl influenza virus antibody.
Owner:ZHEJIANG GONGSHANG UNIVERSITY

Influenza virus antibody detection method based on eukaryotic cell agglutination reaction of recombined expression influenza virus hemagglutinin

The invention relates to the field of biotechnology, particularly an influenza virus antibody detection method based on the eukaryotic cell agglutination reaction of recombined expression influenza virus hemagglutinin. In the detection method, influenza virus hemagglutinin genes are cloned and transfect eukaryotic cells, so that the surfaces of the eukaryotic cells express the influenza virus hemagglutinin protein in a recombined mode; the protein is combined with the influenza virus hemagglutinin antibody in the sample to be detected to produce agglutination reaction; and the influenza virus antibody in the sample to be detected is detected according to whether the agglutination reaction occurs. The detection method is quick and stable, and can be widely used for quickly detecting different serotypes of influenza virus antibodies.
Owner:SHANTOU UNIV MEDICAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products